MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 232 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $23,357,780 | -5.1% | 83,373 | -9.6% | 0.04% | -4.4% |
| Q1 2024 | $24,625,894 | +73.3% | 92,218 | +50.2% | 0.04% | +60.7% |
| Q4 2023 | $14,209,509 | +90.6% | 61,412 | +20.3% | 0.03% | +75.0% |
| Q3 2023 | $7,454,904 | -21.7% | 51,047 | +23.9% | 0.02% | -15.8% |
| Q2 2023 | $9,516,507 | +41.4% | 41,197 | +48.3% | 0.02% | +26.7% |
| Q1 2023 | $6,729,014 | +2158.1% | 27,776 | +506.5% | 0.02% | +1400.0% |
| Q3 2022 | $298,000 | -68.2% | 4,580 | -65.0% | 0.00% | -50.0% |
| Q2 2022 | $937,000 | +512.4% | 13,088 | +739.0% | 0.00% | – |
| Q1 2022 | $153,000 | +15.9% | 1,560 | 0.0% | 0.00% | – |
| Q4 2021 | $132,000 | – | 1,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |